Tom Morrison

Chief Scientific Officer at Accugenomics

Dr. Morrison has more than 10 years of experience developing and commercializing technologies in emerging and mid-sized Life Sciences companies, with an emphasis on the diagnostics testing market and technologies in the last four years. Dr. Morrison’s experience and leadership further AccuGenomics’ goals in internal standard development and optimization, commercial product development and launch, and development of a strong product pipeline. Prior to joining AccuGenomics, Dr. Morrison served as Senior Director at BioTrove (now part of LifeTechnologies), a nanoplate-based genomics company. Previous to this role he was director of protein engineering at the industrial enzyme company Genencor. Dr. Morrison received his Ph.D. from the University of Utah, Salt Lake City and his B.A. from the University of California, Berkeley.


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Accugenomics

AccuGenomics is a developer of a unique spike-in control technology that dramatically improves the accuracy and performance of clinical sequencing tests for low abundance biomarkers such as circulating tumor DNA (ctDNA) and low titer infectious pathogens such as SARS-CoV-2.


Industries

Employees

1-10

Links